| abstract |
The present invention relates to a peptide that modulates IgG levels in serum by binding to human FcRn and inhibiting the binding of the Fc portion of IgG to FcRn. The compositions and methods disclosed herein can be used, for example, in the treatment of autoimmune diseases and inflammatory diseases. The invention also relates to methods of using the peptides of the invention and to methods of making the same. |